Jacobs Receives EPCM Contract from Novartis

Jacobs Engineering Group Inc. is providing engineering, procurement, and construction management services for Novartis' new manufacturing facility to be located in Holly Springs, N.C.

The new facility will produce trivalent pandemic and interpandemic influenza vaccines utilizing an innovative cell culture based process for U.S. and overseas markets. Jacobs is providing services on-site and from its Cincinnati office.

In making the announcement, Jacobs Group Vice President Arlan Emmert stated, "Flu pandemics are by their nature global issues. We are pleased to be playing this significant role preparing for a potential pandemic with a premier global vaccine producer like Novartis."

Find out more about  Jacobs

Search for more Jacobs News

Posted 03/07/07

Back